MGMT and central nervous system cancer: The 'proportion of non-enhancing 68–100%' feature presents an OR of 0.215 (p = 0.009) for being an MGMT-unmethylated glioma, implying that the larger the non-enhancing area, the greater the likelihood of the glioma being MGMT-methylated.